Latest news with #YatharthHospital&TraumaCareServices
Business Standard
a day ago
- Business
- Business Standard
Yatharth Hospital gains on MSCI entry
Yatharth Hospital & Trauma Care Services gained 1.27% to Rs 715 after being slated for inclusion in the MSCI India Small Cap Index, effective from the upcoming rebalancing on 26 August 2025. The index tracks the performance of the small-cap segment of the Indian equity market and is closely followed by global institutional investors. Yatharth Hospitals operates seven super speciality hospitals across Noida, Greater Noida, Noida Extension, Greater Faridabad, the newly opened Model Town facility, the soon-to-be operational Faridabad facility in Delhi NCR, and Jhansi-Orchha in Madhya Pradesh, with a total capacity of over 2,300 beds. On a consolidated basis, net profit of Yatharth Hospital & Trauma Care Services rose 38.38% to Rs 42.04 crore while net sales rose 21.72% to Rs 257.77 crore in Q1 June 2025 over Q1 June 2024.
&w=3840&q=100)
Business Standard
a day ago
- Business
- Business Standard
Yatharth hits new high, zooms 52% in 3 months; what's driving the rally?
Yatharth Hospital & Trauma Care Services share price today: Shares of Yatharth Hospital & Trauma Care Services (Yatharth Hospitals) hit a new high of ₹738, as they rallied nearly 5 per cent on the BSE in Monday's intra-day trade. In the past two weeks, the stock price of one of the leading private super speciality hospitals in North India has surged 20 per cent. In the past three months, it zoomed 52 per cent. In the past six months, the stock rallied nearly 80 per cent, as compared to 5 per cent rise in the BSE Sensex. What's the trigger behind the rally in Yatharth Hospitals? Yatharth Hospitals is set to be included as a constituent of the MSCI India Small Cap Index, effective from the upcoming index rebalancing date of August 26, 2025. The MSCI India Small Cap Index is designed to measure the performance of the small cap segment of the Indian equity market. The MSCI indices are widely tracked by international institutional investors, and this addition is set to enhance the Yatharth Hospital's visibility amongst global investors, the company said in a press release. Over the past four years, Yatharth Hospitals has delivered a robust revenue compounded annual growth rate (CAGR) of 40 per cent and a profit after tax (PAT) CAGR of 61 per cent. This remarkable growth underscores the increasing influence of the Yatharth brand and its position as a leading healthcare provider in North India. The company's success is attributed to significant investments in state-of-the-art medical technologies, focus on clinical excellence and the dedication of its medical practitioners and staff, it said. Yatharth Hospitals is on course to surpass its target of 3,000 beds by FY28, driven by a strategic capacity expansion focused on strengthening its footprint in the highgrowth Delhi-NCR region. The new hospitals in Faridabad and New Delhi will offer super-specialty services from day one, ensuring higher average revenue per occupied bed (ARPOB) and enabling a faster ramp-up. With Ebitda breakeven anticipated within 12–15 months of commissioning, this expansion is expected to propel robust volume growth and enhance operating leverage, according to analysts at Choice Equity Broking. 'We expect growth to be driven by higher ARPOB, improved occupancy levels (aiming for 70 per cent across existing facilities), strategic acquisitions, and a sustained revenue growth trajectory of +30 per cent. Additionally, an increasing share of super-specialty services is anticipated to enhance their contribution to Yatharth's overall revenues,' the brokerage firm said with a 'buy' rating on stock and target price of ₹800 per share. In the coming years, healthcare delivery in India is expected to be primarily shaped by technological advancements and the growing adoption of digital health solutions by both providers and patients. This transformation will be fueled by shifts in mindset, advancements in technology, infrastructure development, government initiatives, and more. Key government programmes, such as the Ayushman Bharat Digital Mission (ABDM) and e-Sanjeevani, are laying the groundwork for a digitised healthcare ecosystem. At the same time, private sector players are exploring digital technologies like robotics, telehealth, AI, and 5G to offer technology-driven care to their patients. Overall, the Indian healthcare industry has maintained robust growth momentum and is poised for continued expansion, fuelled by strong government support, rising private sector investments, technological advancements, and a steadfast commitment to enhancing healthcare access and affordability for all segments of the population, Fortis Healthcare said in FY25 annual report. About Yatharth Hospital & Trauma Care Services Yatharth Hospitals is one of North India's leading healthcare providers. With seven super speciality hospitals located in North India, i.e., at Noida, Greater Noida, Noida Extension, Greater Faridabad, newly operationalised Model Town facility, and soon to be operationalised Faridabad facility in Delhi NCR, and Jhansi-Orchha in Madhya Pradesh, it has a total capacity of more than 2,300 beds.
&w=3840&q=100)
Business Standard
5 days ago
- Business
- Business Standard
Yatharth, Fortis jump up to 4%, record new highs; what triggered the rally?
Fortis Healthcare, Yatharth Hospital & Trauma Care Services shares price today Shares of Fortis Healthcare and Yatharth Hospital & Trauma Care Services (Yatharth) hit their respective new highs on the BSE in Thursday's intra-day trade in an otherwise weak market. Shares of Fortis Healthcare rallied 4 per cent to ₹892.70, while the stock price of Yatharth gained 2.4 per cent at ₹719 on the BSE. In comparison, the BSE Sensex was down 0.18 per cent at 80,395 at 09:32 AM. In the past six months, the stock price of Yatharth has zoomed 66 per cent and of Fortis 35 per cent, as against 3 per cent rise in the benchmark index. CATCH STOCK MARKET LATEST UPDATES LIVE What's driving hospital stocks? Fortis Healthcare and Yatharth reported strong earnings for the quarter ended June 2025 (Q1FY26). Fortis Healthcare on Wednesday reported a 53 per cent year-on-year (Y-o-Y) rise in consolidated net profit for Q1FY26 at ₹266.78 crore, up from ₹173.98 crore in the same period last year. Revenue from operations rose 16.6 per cent to ₹2,167 crore in Q1FY26 from ₹1,859 crore in Q1FY25. Consolidated earnings before interest, tax, depreciation, and amortisation (EBITDA) grew 43.2 per cent Y-o-Y to ₹491 crore, with the Ebitda margin improving to 22.6 per cent from 18.4 per cent a year earlier. Fortis attributed the growth to strong performances in both its hospital and diagnostics businesses. In the diagnostics business, the company witnessed a strong recovery in both revenues and EBITDA margins which is reflective of the brand building initiatives undertaken over the last few quarters. The management expects this growth momentum to continue going forward. Meanwhile, Yatharth has reported 40 per cent Y-o-Y jump in profit after tax at ₹42.5 crore. EBITDA at ₹64.5 crore, was up 20 per cent Y-o-Y and 13 per cent quarter-on-quarter (Q-o-Q), reflecting 13 consecutive quarters of EBITDA growth. EBITDA margin improved 41 bps Q-o-Q to 25.0 per cent. Operating revenue was at ₹257.8 crore, up 22 per cent Y-o-Y and 11 per cent Q-o-Q. Bed occupancy increased to 65 per cent, from 61 per cent in Q1FY25. With the Model Town and the Faridabad facility, having a combined capacity of 700+ beds, the management expects to further accelerate the company's growth momentum from Q2FY26 onwards. Future Outlook In the coming years, healthcare delivery in India is expected to be primarily shaped by technological advancements and the growing adoption of digital health solutions by both providers and patients. This transformation will be fueled by shifts in mindset, advancements in technology, infrastructure development, government initiatives, and more. Key government programs, such as the Ayushman Bharat Digital Mission (ABDM) and e-Sanjeevani, are laying the groundwork for a digitised healthcare ecosystem. At the same time, private sector players are exploring digital technologies like robotics, telehealth, AI, and 5G to offer technology-driven care to their patients. Overall, the Indian healthcare industry has maintained robust growth momentum and is poised for continued expansion, fuelled by strong government support, rising private sector investments, technological advancements, and a steadfast commitment to enhancing healthcare access and affordability for all segments of the population, Fortis Healthcare said in FY25 annual report.
Business Standard
05-08-2025
- Business
- Business Standard
Yatharth Hospital & Trauma Care Services consolidated net profit rises 38.38% in the June 2025 quarter
Sales rise 21.72% to Rs 257.77 croreNet profit of Yatharth Hospital & Trauma Care Services rose 38.38% to Rs 42.04 crore in the quarter ended June 2025 as against Rs 30.38 crore during the previous quarter ended June 2024. Sales rose 21.72% to Rs 257.77 crore in the quarter ended June 2025 as against Rs 211.78 crore during the previous quarter ended June EndedJun. 2025Jun. 2024% 22 OPM %25.0225.34 -PBDT73.6154.40 35 PBT58.6942.96 37 NP42.0430.38 38 Powered by Capital Market - Live News
Economic Times
17-07-2025
- Business
- Economic Times
Mukul Agrawal picks 1.14% stake in smallcap stock in Q1FY26
Ace investor Mukul Mahavir Agrawal acquired a 1.14% stake in Yatharth Hospital & Trauma Care Services in the June 2025 quarter, purchasing 11 lakh shares worth around Rs 68.1 crore. Following the update, the stock rose 3% in Thursday's trade on the BSE and has rallied 40% over the last six months. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Ace investor Mukul Mahavir Agrawal picked up a 1.14% stake in small-cap Yatharth Hospital & Trauma Care Services during the June 2025 quarter, as per the latest shareholding acquired 11,00,000 shares, valued at approximately Rs 68.1 crore based on the current market price of Rs today's trade, Yatharth Hospital shares surged 3% on BSE. The stock has gained 40% over the past six the same quarter, he also increased his stake in small-cap multibagger Prakash Industries by 0.3%, taking his total holding to 1.72% or 30,27,554 earlier, Agrawal also trimmed his holdings in two small-cap stocks Sula Vineyards and Raghav Productivity Enhancers — during the quarter ended June 30, 2025. His stake in Sula Vineyards fell by 41 basis points (bps) over the March quarter, bringing his current holding to 1.78%. In Raghav Productivity, the stake was reduced by 51 bps to 1.04%, according to BSE reduction in Sula Vineyards comes amid sustained underperformance, with the stock losing 40% over the past year and 28% in 2025 so contrast, Raghav Productivity had rallied 56% in the last 12 months, outperforming the Nifty's 2% gain during the same period. The recent trimming appears to be profit-booking, especially as the stock has declined over 5% in 2025, while the Nifty has gained more than 5%.Agrawal, known for identifying multibaggers, publicly holds 61 stocks with a combined net worth of over Rs 6,870 crore as of the June quarter. His top holdings include Neuland Laboratories, BSE, Radico Khaitan, Nuvama Wealth, Deepak Fertilisers, Intellect Design, and PTC the June quarter, Agrawal also added SME stock Monolithisch India to his portfolio, purchasing 5 lakh shares or a 2.30% stake. Additionally, he acquired a 1.27% stake in Jammu & Kashmir Bank.: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times)
